Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 26 January 2006. doi:10.1136/ard.2005.045971
Annals of the Rheumatic Diseases 2006;65:1414-1421
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ard.2005.045971v1
65/11/1414    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaney Davidson, E N
Right arrow Articles by van den Berg, W B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaney Davidson, E N
Right arrow Articles by van den Berg, W B

EXTENDED REPORT

Expression of transforming growth factor-ß (TGFß) and the TGFß signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation

E N Blaney Davidson , E L Vitters , P M van der Kraan , W B van den Berg

Experimental Rheumatology and Advanced Therapeutics, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands

Correspondence to:
Correspondence to:
P M van der Kraan
Experimental Rheumatology and Advanced Therapeutics, Radboud University Medical Centre, Geert Grooteplein 26-28, 6525 GA Nijmegen, The Netherlands;p.vanderkraan{at}reuma.umcn.nl

Background: The primary feature of osteoarthritis is cartilage loss. In addition, osteophytes can frequently be observed. Transforming growth factor-ß (TGFß) has been suggested to be associated with protection against cartilage damage and new cartilage formation as seen in osteophytes.

Objective: To study TGFß and TGFß signalling in experimental osteoarthritis to gain insight into the role of TGFß in cartilage degradation and osteophyte formation during osteoarthritis progression.

Methods: Histological sections of murine knee joints were stained immunohistochemically for TGFß3 and phosphorylated SMAD-2 (SMAD-2P). Expression patterns were studied in two murine osteoarthritis models, representing spontaneous (STR/ort model) and instability-associated osteoarthritis (collagenase-induced instability model).

Results: TGFß3 and SMAD-2P staining was increasingly reduced in cartilage during osteoarthritis progression in both models. Severely damaged cartilage was negative for TGFß3. In contrast, bone morphogenetic protein-2 (BMP-2) expression was increased. In chondrocyte clusters, preceding osteophyte formation, TGFß3 and SMAD-2P were strongly expressed. In early osteophytes, TGFß3 was found in the outer fibrous layer, in the peripheral chondroblasts and in the core. Late osteophytes expressed TGFß3 only in the fibrous layer. SMAD-2P was found throughout the osteophyte at all stages. In the late-stage osteophytes, BMP-2 was strongly expressed.

Conclusion: Data show that lack of TGFß3 is associated with cartilage damage, suggesting loss of the protective effect of TGFß3 during osteoarthritis progression. Additionally, our results indicate that TGFß3 is involved in early osteophyte development, whereas BMP might be involved in late osteophyte development.


Abbreviations: BMP-2, bone morphogenetic protein-2; ECM, extracellular matrix; TGF-ß, transforming growth factor-ß







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism